|
mouse pachytene spermatocytes |
5 |
|
non-homologous xy desynapsis |
5 |
|
spdya |
5 |
|
telomeres |
5 |
|
xy loop-axis organization |
5 |
|
metabolomics |
2 |
|
18 f-flt pet |
1 |
|
[18f]fluoropivalate |
1 |
|
apoa1 mimetic peptides |
1 |
|
apolipoprotein a1 |
1 |
|
artificial intelligence |
1 |
|
biomarkers |
1 |
|
choline kinase |
1 |
|
choline kinase alpha (chka) inhibitor |
1 |
|
cna |
1 |
|
computational biology |
1 |
|
contrast-enhanced magnetic resonance imaging |
1 |
|
detection |
1 |
|
efflux |
1 |
|
epithelial ovarian cancer |
1 |
|
hepatocellular cancer |
1 |
|
hypoxia |
1 |
|
icl-ccic-0019 |
1 |
|
immunotherapy |
1 |
|
interferon inducers |
1 |
|
intracranial metastatic disease |
1 |
|
invasiveness |
1 |
|
lateral-flow immunoassay |
1 |
|
lipidomics |
1 |
|
lung cancer |
1 |
|
metabolic (dysfunction) associated fatty liver disease |
1 |
|
non–small cell lung cancer |
1 |
|
nsclc |
1 |
|
ovarian cancer |
1 |
|
pci |
1 |
|
peritoneum |
1 |
|
pet |
1 |
|
pik4cb |
1 |
|
platinum nanoparticles |
1 |
|
platinum sensitization |
1 |
|
pneumonitis |
1 |
|
positron emission tomography |
1 |
|
precision medicine |
1 |
|
prodrug |
1 |
|
prognostication |
1 |
|
psma |
1 |
|
radiogenomics |
1 |
|
radiomics |
1 |
|
response |
1 |
|
risk stratification |
1 |
|
stereotactic radiosurgery |
1 |
|
surgical outcome |
1 |
|
survival |
1 |
|
targeted drug delivery |
1 |
|
tertiary lymphoid structures |
1 |
|
tumor |
1 |
